专利检索 ap:("FORMA Therapeutics, Inc.") AND inv:"Jun Huang" 第 1 页

1.

发明授权
Solid forms of (4-(2-fluoro-4-(1-methyl-1H-benzo[d]imidazol-5-yl)benzoyl) piperazine-1-yl)(1-hydroxycyclopropyl)methanone 有权

公开(公告)号：US11267805B2

公开(公告)日：2022-03-08

申请号：US17006317

申请日：2020-08-28

申请人： FORMA Therapeutics, Inc.

发明人： George P. Luke , Stephen Hubbs , Matthew W. Martin , Shawn E. R. Schiller , Robert Wenslow , Yawei Shi , Jun Huang

IPC分类号： C07D403/10 , A61K31/665

摘要： The present disclosure reports solid forms of (4-(2-fluoro-4-(1-methyl-1H-benzo[d]imidazol-5-yl)benzoyl)piperazin-1-yl)(1-hydroxycyclopropyl)methanone:

2.

发明授权
Solid forms of 4-(2-fluoro-4-(1-methyl-1H-benzo[d]imidazol-5-yl)benzoyl)piperazin-1-yl)(1-hydroxycyclopropyl)methanone 有权

公开(公告)号：US10793554B2

公开(公告)日：2020-10-06

申请号：US16667602

申请日：2019-10-29

申请人： FORMA Therapeutics, Inc.

发明人： George P. Luke , Stephen Hubbs , Matthew W. Martin , Robert Wenslow , Yawei Shi , Jun Huang

IPC分类号： C07D403/10

摘要： The present disclosure reports solid forms of (4-(2-fluoro-4-(1-methyl-1H- benzo[d]imidazol-5-yl)benzoyl)piperazin-1-yl)(1-hydroxycyclopropyl)methanone: